MTFP1
gene geneOn this page
Also known as MTP18HSPC242
Summary
MTFP1 (mitochondrial fission process 1, HGNC:26945) is a protein-coding gene on chromosome 22q12.2, encoding Mitochondrial fission process protein 1 (Q9UDX5). Involved in the mitochondrial division probably by regulating membrane fission.
MTP18 is a mitochondrial protein and downstream target of the phosphatidylinositol 3-kinase (see PIK3CA, MIM 171834) signaling pathway that plays a role in cell viability and mitochondrial dynamics (Tondera et al., 2004 [PubMed 15155745]).
Source: NCBI Gene 51537 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_016498
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26945 |
| Approved symbol | MTFP1 |
| Name | mitochondrial fission process 1 |
| Location | 22q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MTP18, HSPC242 |
| Ensembl gene | ENSG00000242114 |
| Ensembl biotype | protein_coding |
| OMIM | 610235 |
| Entrez | 51537 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000266263, ENST00000355143, ENST00000407550, ENST00000412752, ENST00000614920, ENST00000629597, ENST00000862422, ENST00000933114, ENST00000933115, ENST00000933116
RefSeq mRNA: 2 — MANE Select: NM_016498
NM_001003704, NM_016498
CCDS: CCDS33634, CCDS33635
Canonical transcript exons
ENST00000266263 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001818761 | 30425768 | 30425946 |
| ENSE00001920444 | 30428462 | 30429054 |
| ENSE00003627770 | 30426717 | 30426844 |
| ENSE00003682123 | 30427171 | 30427403 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 93.57.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.6794 / max 86.2846, expressed in 1752 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 191685 | 9.0922 | 1692 |
| 191686 | 3.7397 | 1391 |
| 191684 | 0.8476 | 542 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 93.57 | gold quality |
| apex of heart | UBERON:0002098 | 92.08 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.13 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.99 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.65 | gold quality |
| cortex of kidney | UBERON:0001225 | 87.99 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.90 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.16 | gold quality |
| right atrium auricular region | UBERON:0006631 | 87.08 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.79 | gold quality |
| esophagus mucosa | UBERON:0002469 | 86.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.36 | gold quality |
| duodenum | UBERON:0002114 | 86.16 | gold quality |
| kidney | UBERON:0002113 | 86.03 | gold quality |
| spleen | UBERON:0002106 | 85.98 | gold quality |
| heart | UBERON:0000948 | 85.75 | gold quality |
| lymph node | UBERON:0000029 | 85.51 | gold quality |
| muscle of leg | UBERON:0001383 | 85.26 | gold quality |
| transverse colon | UBERON:0001157 | 85.24 | gold quality |
| body of stomach | UBERON:0001161 | 85.24 | gold quality |
| granulocyte | CL:0000094 | 84.97 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 84.92 | gold quality |
| placenta | UBERON:0001987 | 84.63 | gold quality |
| blood | UBERON:0000178 | 84.45 | gold quality |
| body of pancreas | UBERON:0001150 | 84.18 | gold quality |
| right adrenal gland | UBERON:0001233 | 83.69 | gold quality |
| left adrenal gland | UBERON:0001234 | 83.62 | gold quality |
| bone marrow cell | CL:0002092 | 83.22 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting MTFP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-377-5P | 99.70 | 65.28 | 712 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-877-3P | 99.09 | 68.10 | 1637 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
| HSA-MIR-6818-3P | 98.56 | 68.23 | 1307 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-7843-3P | 98.31 | 67.94 | 803 |
| HSA-MIR-6867-3P | 98.12 | 66.07 | 1305 |
| HSA-MIR-4691-3P | 98.11 | 66.83 | 1204 |
| HSA-MIR-5196-3P | 97.57 | 65.98 | 979 |
| HSA-MIR-4308 | 97.56 | 67.13 | 1385 |
| HSA-MIR-3157-5P | 97.41 | 67.61 | 998 |
| HSA-MIR-1245A | 96.33 | 66.25 | 498 |
Literature-anchored findings (GeneRIF, showing 7)
- MTP18 mRNA as well as protein expression is dependent on PI 3-kinase activity. (PMID:15155745)
- the results suggest that miR-668 is induced via HIF-1 in ischemic AKI and that, upon induction, miR-668 represses MTP18 to preserve mitochondrial dynamics for renal tubular cell survival and kidney protection. (PMID:30325740)
- MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production. (PMID:31814213)
- MiR-125b-5p Targets MTFP1 to Inhibit Cell Proliferation, Migration, and Invasion and Facilitate Cell Apoptosis in Endometrial Carcinoma. (PMID:36380260)
- The inner mitochondrial membrane fission protein MTP18 serves as a mitophagy receptor to prevent apoptosis in oral cancer. (PMID:37313742)
- Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models. (PMID:38042218)
- MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels. (PMID:38851188)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | MTFP1 | ENSDARG00000099908 |
| mus_musculus | Mtfp1 | ENSMUSG00000004748 |
| rattus_norvegicus | Mtfp1 | ENSRNOG00000004640 |
| drosophila_melanogaster | CG7772 | FBGN0030883 |
| caenorhabditis_elegans | WBGENE00077690 |
Protein
Protein identifiers
Mitochondrial fission process protein 1 — Q9UDX5 (reviewed: Q9UDX5)
Alternative names: Mitochondrial 18 kDa protein
All UniProt accessions (3): B5MC22, Q9UDX5, F8WEN7
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the mitochondrial division probably by regulating membrane fission. Loss-of-function induces the release of cytochrome c, which activates the caspase cascade and leads to apoptosis.
Subcellular location. Mitochondrion inner membrane.
Induction. Expression is regulated by the phosphatidylinositol (PI) 3-kinase pathway.
Similarity. Belongs to the MTFP1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UDX5-1 | 1 | yes |
| Q9UDX5-2 | 2 |
RefSeq proteins (2): NP_001003704, NP_057582* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019560 | Mitochondrial_18_kDa_protein_ | Family |
Pfam: PF10558
UniProt features (7 total): transmembrane region 3, chain 1, modified residue 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UDX5-F1 | 86.86 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 123
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 95 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, YY1_Q6, GOBP_ORGANELLE_FISSION, GOBP_MITOCHONDRIAL_FISSION, YY1_02, GOCC_MITOCHONDRIAL_ENVELOPE, DOUGLAS_BMI1_TARGETS_UP, GOCC_ORGANELLE_INNER_MEMBRANE, MYCMAX_03, ATGGYGGA_UNKNOWN, CHEN_METABOLIC_SYNDROM_NETWORK, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, GOCC_ORGANELLE_ENVELOPE
GO Biological Process (3): mitochondrial fission (GO:0000266), apoptotic process (GO:0006915), mitochondrion organization (GO:0007005)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion organization | 1 |
| organelle fission | 1 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| organelle organization | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
590 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTFP1 | DNM1L | O00429 | 900 |
| MTFP1 | PIK3CB | P42338 | 650 |
| MTFP1 | FIS1 | Q9Y3D6 | 564 |
| MTFP1 | CYCS | P00001 | 548 |
| MTFP1 | MFF | Q9GZY8 | 507 |
| MTFP1 | MFN1 | Q8IWA4 | 490 |
| MTFP1 | MFN2 | O95140 | 488 |
| MTFP1 | MIEF2 | Q96C03 | 479 |
| MTFP1 | MIEF1 | Q9NQG6 | 452 |
| MTFP1 | GDAP1 | Q8TB36 | 442 |
| MTFP1 | TFRC | P02786 | 441 |
| MTFP1 | PIK3CA | P42336 | 440 |
| MTFP1 | PINK1 | Q9BXM7 | 434 |
| MTFP1 | PIK3CG | P48736 | 425 |
| MTFP1 | SNX15 | Q9NRS6 | 420 |
IntAct
51 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MTFP1 | OPTN | psi-mi:“MI:0915”(physical association) | 0.560 |
| TOR1AIP2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM108 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| VSIG4 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC39A9 | B4GALT5 | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| MTFP1 | CDKN2D | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMR3B | MTFP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| TM2D3 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| OPRM1 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| NCEH1 | C1QL1 | psi-mi:“MI:0914”(association) | 0.350 |
| AP3B1 | psi-mi:“MI:0914”(association) | 0.350 | |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| ERGIC3 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| SV2A | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| MLNR | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC25 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| OPRL1 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A4 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| AQP3 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| KCNE1 | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| CMTM8 | UBXN8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (46): MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Affinity Capture-MS), MTFP1 (Proximity Label-MS)
ESM2 similar proteins: A0A067XMT5, A0A0E3D8L0, A0A0M4KRN2, A0A140JWS9, A0A194XJW1, A0A1V6NWP3, A0A1V6NYL5, A0A1W5T1Y3, A0A2I1C3V3, A0A411PQQ5, A0A455LLW3, A0A455LLW7, A0A455M7R7, A0A455R4Z0, A0A4P8DK01, A0A7L9EYL3, A0A8F4NWB9, A0A8F4S8P5, A4DA06, A4DA85, A7THN6, A9JPE4, B0D4E6, B8NI03, C5DRF7, D2E9W6, E3UBL5, G0LET6, I1RAL7, M1VWN5, M2WJF5, M3APK4, P0CM32, P0CM33, P0DOB2, P0DXW0, P9WEG7, P9WEV9, Q06089, Q0C9L5
Diamond homologs: B6IJ52, Q6PCS6, Q8T3C8, Q9CRB8, Q9UDX5
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EIF4E | “up-regulates activity” | MTFP1 | “translation regulation” |
| MTFP1 | “up-regulates activity” | DNM1L | relocalization |
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
725 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:30426712:CCCA:C | acceptor_loss | 1.0000 |
| 22:30426713:CCA:C | acceptor_loss | 1.0000 |
| 22:30426714:CA:C | acceptor_loss | 1.0000 |
| 22:30426716:GGCT:G | acceptor_gain | 1.0000 |
| 22:30426842:GAG:G | donor_gain | 1.0000 |
| 22:30426843:AGG:A | donor_loss | 1.0000 |
| 22:30426845:G:A | donor_loss | 1.0000 |
| 22:30426845:G:GG | donor_gain | 1.0000 |
| 22:30426845:GT:G | donor_loss | 1.0000 |
| 22:30426846:T:A | donor_loss | 1.0000 |
| 22:30426715:A:AG | acceptor_gain | 0.9900 |
| 22:30426715:A:AT | acceptor_loss | 0.9900 |
| 22:30426715:AG:A | acceptor_gain | 0.9900 |
| 22:30426716:G:GA | acceptor_gain | 0.9900 |
| 22:30426716:G:GG | acceptor_gain | 0.9900 |
| 22:30426716:GG:G | acceptor_gain | 0.9900 |
| 22:30426716:GGC:G | acceptor_gain | 0.9900 |
| 22:30426840:GAGAG:G | donor_gain | 0.9900 |
| 22:30427302:T:G | acceptor_gain | 0.9900 |
| 22:30427400:ACAG:A | donor_loss | 0.9900 |
| 22:30427400:ACAGG:A | donor_loss | 0.9900 |
| 22:30427401:CAG:C | donor_loss | 0.9900 |
| 22:30427402:AG:A | donor_loss | 0.9900 |
| 22:30427404:G:A | donor_loss | 0.9900 |
| 22:30427404:GT:G | donor_loss | 0.9900 |
| 22:30427405:T:G | donor_loss | 0.9900 |
| 22:30428457:TACA:T | acceptor_loss | 0.9900 |
| 22:30428459:CA:C | acceptor_loss | 0.9900 |
| 22:30428460:AGGTC:A | acceptor_gain | 0.9900 |
| 22:30428461:G:A | acceptor_loss | 0.9900 |
AlphaMissense
1045 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:30426779:A:C | S44R | 0.996 |
| 22:30426781:C:A | S44R | 0.996 |
| 22:30426781:C:G | S44R | 0.996 |
| 22:30425946:G:C | G23R | 0.993 |
| 22:30427247:C:A | A91D | 0.993 |
| 22:30426794:A:C | S49R | 0.991 |
| 22:30426796:C:A | S49R | 0.991 |
| 22:30426796:C:G | S49R | 0.991 |
| 22:30427234:T:A | W87R | 0.991 |
| 22:30427234:T:C | W87R | 0.991 |
| 22:30427236:G:C | W87C | 0.991 |
| 22:30427236:G:T | W87C | 0.991 |
| 22:30427259:T:A | I95N | 0.991 |
| 22:30427280:G:C | R102P | 0.991 |
| 22:30426815:G:C | A56P | 0.990 |
| 22:30426735:G:A | G29D | 0.989 |
| 22:30427400:A:T | D142V | 0.989 |
| 22:30426717:G:A | G23D | 0.988 |
| 22:30427376:T:A | I134N | 0.988 |
| 22:30427397:T:A | I141N | 0.988 |
| 22:30427400:A:C | D142A | 0.988 |
| 22:30427364:G:A | G130E | 0.987 |
| 22:30427249:T:C | S92P | 0.986 |
| 22:30427265:G:A | G97D | 0.986 |
| 22:30427223:A:T | D83V | 0.985 |
| 22:30427262:C:A | P96Q | 0.984 |
| 22:30426719:T:C | Y24H | 0.983 |
| 22:30426734:G:C | G29R | 0.983 |
| 22:30427274:T:A | I100N | 0.983 |
| 22:30427363:G:A | G130R | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000214975 (22:30428396 C>G,T), RS1000696529 (22:30424827 G>T), RS1001144713 (22:30429148 A>G), RS1001513656 (22:30429375 A>G), RS1001762819 (22:30427709 T>G), RS1001964669 (22:30426010 G>A,C), RS1002315552 (22:30425823 G>C), RS1002546543 (22:30425942 C>G,T), RS1002628727 (22:30428789 C>T), RS1002765650 (22:30426276 A>C), RS1002984934 (22:30428563 G>A), RS1003769389 (22:30424994 T>C), RS1004287938 (22:30427108 G>A), RS1004319297 (22:30426834 A>C,G), RS1004457212 (22:30425623 A>C)
Disease associations
OMIM: gene MIM:610235 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001585_24 | Breast size | 4.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
41 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression, increases expression | 4 |
| Nickel | increases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| chloroacetaldehyde | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Cidofovir | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Diuron | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Ibuprofen | increases expression | 1 |
| Ifosfamide | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1XT | Abcam HeLa MTFP1 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.